OSCR - CIK 0001568651
The table below shows Oscar Health, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $1.09B | $978.19M | -$272.16M | $380.35M | -$181.75M | $222.73M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$241.06M | -$1.39B | $577.19M | -$226.52M | -$774.51M | -$344.71M |
| Dividends paid | - | - | - | - | - | - |
Oscar Health, Inc. reported operating cash flow of $1.09B for fiscal year 2025. That is up 11.9% from $978.19M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow grew from -$165.37M (FY 2019) to $1.09B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | $0.00 | $0.00 |
| Financing cash flow | $399.21M | $68.39M | $6.45M | $301.11M | $1.24B | $611.71M |